XML 17 R5.htm IDEA: XBRL DOCUMENT v3.24.0.1
Condensed Consolidated Statements of Changes in Stockholders' Equity - USD ($)
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Other Comprehensive Loss
Total
Balance at Jun. 30, 2022 $ 27,076 $ 28,072,855 $ (23,094,272) $ (121,941) $ 4,883,718
Balance (in shares) at Jun. 30, 2022 27,075,648        
Fair value of vested stock options   301,737     301,737
Fair value of vested restricted common stock $ 2,022 480,305     482,327
Fair value of vested restricted common stock (in shares) 2,022,334        
Repurchase of common stock $ (25) (48,704)     (48,729)
Repurchase of common stock (in shares) (25,800)        
Fair value of vested unrestricted common stock $ 36 68,236     68,272
Fair value of vested unrestricted common stock (in shares) 36,509        
Common stock issued upon exercise of stock options $ 46 (46)      
Common stock issued upon exercise of stock options (in shares) 46,046        
Net income (loss) for the period     (40,965)   (40,965)
Foreign currency translation       1,348 1,348
Balance at Dec. 31, 2022 $ 29,155 28,874,383 (23,135,237) (120,593) 5,647,708
Balance (in shares) at Dec. 31, 2022 29,154,737        
Balance at Jun. 30, 2022 $ 27,076 28,072,855 (23,094,272) (121,941) 4,883,718
Balance (in shares) at Jun. 30, 2022 27,075,648        
Balance at Jun. 30, 2023 $ 29,487 29,941,873 (22,522,649) (118,224) 7,330,487
Balance (in shares) at Jun. 30, 2023 29,487,508        
Balance at Sep. 30, 2022 $ 27,331 28,298,171 (22,879,707) (127,117) 5,318,678
Balance (in shares) at Sep. 30, 2022 27,330,878        
Fair value of vested stock options   261,031     261,031
Fair value of vested restricted common stock $ 1,800 345,872     347,672
Fair value of vested restricted common stock (in shares) 1,800,000        
Repurchase of common stock $ (16) (30,651)     (30,667)
Repurchase of common stock (in shares) (16,141)        
Common stock issued upon exercise of stock options $ 40 (40)      
Common stock issued upon exercise of stock options (in shares) 40,000        
Net income (loss) for the period     (255,530)   (255,530)
Foreign currency translation       6,524 6,524
Balance at Dec. 31, 2022 $ 29,155 28,874,383 (23,135,237) (120,593) 5,647,708
Balance (in shares) at Dec. 31, 2022 29,154,737        
Balance at Jun. 30, 2023 $ 29,487 29,941,873 (22,522,649) (118,224) 7,330,487
Balance (in shares) at Jun. 30, 2023 29,487,508        
Fair value of vested stock options   61,714     61,714
Fair value of vested restricted common stock $ 380 1,105,226     1,105,606
Fair value of vested restricted common stock (in shares) 380,000        
Repurchase of common stock $ (27) (68,721)     $ (68,748)
Repurchase of common stock (in shares) (27,104)        
Common stock issued upon exercise of stock options $ 51 (51)      
Common stock issued upon exercise of stock options (in shares) 50,180       319,550
Common stock issued for acquisition of Scite $ 2,729 6,546,905     $ 6,549,634
Common stock issued for acquisition of Scite (in shares) 2,729,014        
Modification cost of stock options   20,949     20,949
Net income (loss) for the period     (1,041,671)   (1,041,671)
Foreign currency translation       5,403 5,403
Balance at Dec. 31, 2023 $ 32,620 37,607,895 (23,564,320) (112,821) 13,963,374
Balance (in shares) at Dec. 31, 2023 32,619,598        
Balance at Sep. 30, 2023 $ 29,624 30,487,415 (23,510,692) (119,170) 6,887,177
Balance (in shares) at Sep. 30, 2023 29,624,085        
Fair value of vested stock options   44,243     44,243
Fair value of vested restricted common stock $ 275 530,988     531,263
Fair value of vested restricted common stock (in shares) 275,000        
Repurchase of common stock $ (8) (22,605)     (22,613)
Repurchase of common stock (in shares) (8,501)        
Common stock issued for acquisition of Scite $ 2,729 6,546,905     6,549,634
Common stock issued for acquisition of Scite (in shares) 2,729,014        
Modification cost of stock options   20,949     20,949
Net income (loss) for the period     (53,628)   (53,628)
Foreign currency translation       6,349 6,349
Balance at Dec. 31, 2023 $ 32,620 $ 37,607,895 $ (23,564,320) $ (112,821) $ 13,963,374
Balance (in shares) at Dec. 31, 2023 32,619,598